Racial/Ethnic Disparities in Dermatology Care: Real-World Strategies to Address Inequities in Treatment and Outcomes

Faculty

Monica E. Peek, MD, MPH, MSc
(she/her/hers)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, IL
Monica E. Peek, MD, MPH, MSc

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.

Candrice R. Heath, MD
Assistant Professor of Dermatology
Director of Pediatric Dermatology
Lewis Katz School of Medicine (LKSOM), Temple University
Philadelphia, PA

Statement of Need

Despite advances in the treatment and management of dermatologic conditions such as psoriasis, significant disparities in both treatment and outcomes persist for patients from racial/ethnic underserved groups. Patients of color are not only more likely to present with more severe disease, but they are also more likely to receive either no treatment, or only topical treatments, despite wide availability of effective biologic medications. In fact, Black patients with moderate to severe psoriasis are 70% less likely to receive biologic treatment than their White counterparts. It is imperative that each member of the multidisciplinary care team works together to address these disparities in order to improve equity in treatment and outcomes for all patients.

In this CMEO BriefCase, expert faculty will utilize case-based learning to illustrate these pervasive disparities through the stories of two patients, Miguel and LaToya, while offering strategies to integrate therapies that optimize long-term outcomes and address racial/ethnic inequities in the diagnosis and treatment of patients with psoriasis.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Implement strategies to improve differential diagnosis and acute treatment of patients with psoriasis
  • Integrate therapies to optimize long-term outcomes in patients with psoriasis

Financial Support

Supported by an educational grant provided by Johnson & Johnson.

Target Audience

Physicians specializing in dermatology or primary care, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hours ( 0.075 CEUs) of continuing pharmacy credit ( JA0007185-0000-24-008-H01-P ).

PAs (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 01/25/2027. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Dr. Peek reports no financial relationships to disclose.

Dr. Heath reports the following financial relationships:

Advisory Board: Arcutis Biotherapeutics, Inc.; Dermavant Sciences, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Johnson & Johnson Consumer Products Company; Pfizer Inc.; Regeneron; Sanofi; Sanofi/ Regeneron Pharmaceuticals Inc.

Consultant: Arcutis Biotherapeutics, Inc.; Avita Medical; L’Oreal USA Inc.

Grants/Research Funding: (paid to institution) Janssen Pharmaceuticals, Inc.

Other financial or material support: WebMD

The following individuals have no financial relationships to disclose: 

Marlon (Tony) Graham, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Morgan Stockberger, MD (Planning Committee)
Jessica Whelan, DNP, APRN, FPMHNP-BC, RN-BC (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

BC-110-012524-57

Racial/Ethnic Disparities in Dermatology Care: Real-World Strategies to Address Inequities in Treatment and Outcomes
Event Date: 01/25/2024 at 5:00 am EST